부광약품

003000KOSPI

51.9 / 100

Reference Date: 2026-09-08

Financial Score22.0 / 40

News Sentiment19.9 / 25

Momentum9.0 / 20

Disclosure1.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 5.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Bupyeong Pharmaceutical, established in 1960, is a pharmaceutical manufacturer and distributor specializing in products like Faloba and Dexid. In 2023, it achieved a profit turnaround with consolidated sales of 160.1 billion won and operating profit of 1.6 billion won, marking a 27% sales growth year-on-year.

Number of Employees

650people

Average Salary

62.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

27.01Industry Average 15.001.5Point

1.8x industry avg (risky)

PBR

1.19Industry Average 1.204.0Point

In line with industry avg

ROE

4.25Industry Average 8.002.5Point

Below industry avg

Debt Ratio

5.15Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲26.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲439.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.6% (improving, 3yr)

Detailed News Sentiment

11 totalPositive 10Neutral 1Negative 0Average Sentiment Score 79.5

Positive
한국유니온제약, 부광약품 지붕 아래서 부활한다
부광약품의 자회사로의 전환으로 인해 한국유니온제약의 회생이 완료되어 긍정적인 시너지 효과 기대.
Positive
한국유니온제약 회생절차 종결…부광약품, 시너지 확대 본격화
부광약품은 자회사 한국유니온제약의 회생절차 종결로 인해 협업 강화와 재무 개선을 통해 실적 향상과 흑자전환을 기대하고 있다.
Positive
부광약품 "자회사 한국유니온제약 회생절차 종결"
부광약품의 자회사 한국유니온제약의 회생절차 종결로 재무 부담 감소 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 4,105Won52-week high 9,60052-week low 3,485

1-month return2.0Point

1m -5.09% (slight drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

6 totalPositive 0Neutral 3Negative 3

Negative출자법인회생절차및파산관련결정2026-08-31
Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-28
Neutral유형자산취득결정2026-08-26
Negative출자법인회생절차및파산관련신청2026-08-14
Negative지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항2026-08-13